Dexamethasone does not diminish sugammadex reversal of neuromuscular block – clinical study in surgical patients undergoing general anesthesia

Table 1 Baseline characteristics for the control and dexamethasone patient groups

Patient baseline characteristic^a	Control group (n = 31)	Dexamethasone group (n = 31)	P
Age [years (interquartile range)]	62 (52–68)	63 (52–71)	0.826
Gender: male [n (%)]	16 (51.6)	16 (51.6)	1.000
Body weight [kg (interquartile range)]	75 (70–88)	74 (63–85)	0.301
American Society of Anesthesiologists physical status (interquartile range)	2 (2–3)	2 (2–3)	0.836
Surgery duration (intubation-extubation time) [h (±standard deviation)]	2.42 (±0.83)	2.35 (±0.54)	0.790
Rocuronium dose per hour [mg/h (±standard deviation)]	41.83 (±12.21)	42.01 (±16.79)	0.525
Sugammadex dose [mg/kg (±standard deviation)]	2.62 (±0.48)	2.81 (±0.58)	0.291
Depth of NMB^b before sugammadex administration [TOF^c (interquartile range)]	0 (0–2)	0 (0–1)	0.070

ISSN: 1471-2253